I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 5 studies | 22% ± 7% | |
| ciliated cell | 5 studies | 32% ± 10% | |
| CD16-positive, CD56-dim natural killer cell, human | 4 studies | 21% ± 4% | |
| epithelial cell | 4 studies | 43% ± 14% | |
| endothelial cell | 4 studies | 24% ± 8% | |
| fibroblast | 4 studies | 20% ± 3% | |
| B cell | 3 studies | 31% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 20% ± 2% | |
| CD4-positive, alpha-beta T cell | 3 studies | 23% ± 2% | |
| CD8-positive, alpha-beta T cell | 3 studies | 24% ± 4% | |
| precursor B cell | 3 studies | 27% ± 8% | |
| basal cell | 3 studies | 38% ± 17% | |
| naive B cell | 3 studies | 19% ± 4% |
